- Home
- RLGT vs ETON Comparison
RLGT vs ETON Comparison
Compare RLGT & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLGT | ETON |
|---|---|---|
| Founded | 2001 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.6M | 498.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | RLGT | ETON |
|---|---|---|
| Price | $6.60 | $16.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $8.00 | ★ $29.67 |
| AVG Volume (30 Days) | 172.7K | ★ 267.4K |
| Earning Date | 02-09-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.35 | N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $925,786,000.00 | $70,316,000.00 |
| Revenue This Year | $3.77 | $113.27 |
| Revenue Next Year | $3.51 | $36.70 |
| P/E Ratio | $20.87 | ★ N/A |
| Revenue Growth | 16.42 | ★ 102.77 |
| 52 Week Low | $5.44 | $11.09 |
| 52 Week High | $7.94 | $23.00 |
Technical Indicators
Market Signals| Indicator | RLGT | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 54.75 | 47.14 |
| Support Level | $6.62 | $15.75 |
| Resistance Level | $6.84 | $17.19 |
| Average True Range (ATR) | 0.17 | 0.70 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 51.82 | 55.03 |
Price Performance
Historical ComparisonAbout RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.